Clinical Trial Update: Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of Mycograb as adjunctive therapy for cryptococcal meningitis in AIDS patients; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis

Drugs mentioned

• Mycograb

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cryptococcal Meningitis | Phase 2 | Status: TERMINATED